Showing results (1881-1890 of 1,963) with videos related to

Sort By:
Pageof 197
RMD Open|November 8, 2023
Factors influencing the kinetics of MSU crystal depletion measured with dual-energy CT in patients with goutVictor Laurent, Charlotte Jauffret, Aurore Pacaud, et al.
RMD Open|November 9, 2023
MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitisChristina Charles-Schoeman, Ernest Choy, Iain B McInnes, et al.
RMD Open|July 21, 2023
Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1-treatment of granulomatosis with polyangiitis and microscopic polyangiitisJan Henrik Schirmer, Beatriz Sanchez-Alamo, Bernhard Hellmich, et al.
RMD Open|July 25, 2023
Clinical profile and treatment utilisation based on HLA-B*27 status in axial spondyloarthritis: results from ASAS-PerSpA studyHaseeb Chaudhary, Clementina López-Medina, Muhammad Asim Khan, et al.
RMD Open|July 17, 2023
Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritisYu-Jih Su, Hui-Ming Chen, Tien-Ming Chan, et al.
RMD Open|July 10, 2023
Fibromyalgia and mortality: a systematic review and meta-analysisYulia Treister-Goltzman, Roni Peleg
RMD Open|August 2, 2023
Systematic literature review informing the EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosisIoannis Parodis, Alvaro Gomez, Alexander Tsoi, et al.
RMD Open|August 4, 2023
The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritisAlan Kivitz, Liangwei Wang, Ilias Alevizos, et al.
RMD Open|August 4, 2023
Fatigue in patients with rheumatic and musculoskeletal diseases: a scoping review on definitions, measurement instruments, determinants, consequences and interventionsEsther Beckers, Kasper Hermans, Astrid Van Tubergen, et al.
RMD Open|July 28, 2023
The 2023 pipeline of disease-modifying antirheumatic drugs (DMARDs) in clinical development for spondyloarthritis (including psoriatic arthritis): a systematic review of trialsAgathe Denis, Cédric Sztejkowski, Laurent Arnaud, et al.
Pageof 197